A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

NCT05538130 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma
Glioma
Thyroid Cancer
Non-Small Cell Lung Cancer
Malignant Neoplasms
Brain Neoplasms
Advanced or Metastatic Solid Tumors
HGG
LGG
Low Grade Glioma
High Grade Glioma
Differentiated Thyroid Cancer
NSCLC (Non-small Cell Lung Cancer)

Interventions

DRUG: PF-07799544
DRUG: PF-07799933

Sponsor

Pfizer